Compare RGTIW & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGTIW | BME |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | 140 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Trusts Except Educational Religious and Charitable |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 534.8M |
| IPO Year | N/A | N/A |
| Metric | RGTIW | BME |
|---|---|---|
| Price | $11.02 | $41.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 850.8K | 34.0K |
| Earning Date | 03-11-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $11,892,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.28 | $35.53 |
| 52 Week High | $4.75 | $43.20 |
| Indicator | RGTIW | BME |
|---|---|---|
| Relative Strength Index (RSI) | 39.86 | 58.50 |
| Support Level | $10.51 | $41.11 |
| Resistance Level | $11.90 | $41.46 |
| Average True Range (ATR) | 1.70 | 0.35 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 9.39 | 79.20 |
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.